GB788100A - Manufacture of polyethylene-glycol esters of substituted p-aminobenzoic acids - Google Patents
Manufacture of polyethylene-glycol esters of substituted p-aminobenzoic acidsInfo
- Publication number
- GB788100A GB788100A GB13008/54A GB1300854A GB788100A GB 788100 A GB788100 A GB 788100A GB 13008/54 A GB13008/54 A GB 13008/54A GB 1300854 A GB1300854 A GB 1300854A GB 788100 A GB788100 A GB 788100A
- Authority
- GB
- United Kingdom
- Prior art keywords
- glycol
- monomethyl ether
- acid
- glycol monomethyl
- ethylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
Abstract
The invention comprises compounds of the formula <FORM:0788100/IV (b)/1> in which R is an alkyl, cycloalkyl or oxa-alkyl residue containing 4-7 carbon atoms, R1 represents hydrogen or a lower alkyl residue of up to 6 carbon atoms such as a methyl group and n is a whole number from 8 to 12 or has an average value between 8 and 12, and acid addition salts of these compounds. The compounds are made by reacting a benzoic acid of the formula <FORM:0788100/IV (b)/2> or a reactive derivative thereof with a polyethylene glycol of the formula HO-(CH2-CH2-O)n-R1 or a reactive derivative thereof. Suitably the benzoic acid or its halide, anhydride or ester with a volatile alcohol is reacted with the polyglycol in the presence of a basic condensing agent or a metal salt of the benzoic acid is reacted with an ester of the glycol. Preferred products include the p-n-butylamino-benzoic acid esters of octa-ethylene glycol monomethyl ether, nona-ethylene glycol monomethyl ether, undeca-ethylene glycol monomethyl ether and nona-ethylene glycol. Examples describe the preparation of esters of p-aminobenzoic acids in which R is chosen from n-hexyl, 3-methoxybutyl, 4-methoxybutyl, n-heptyl, n-butyl, sec.-butyl isoamyl, butoxyethyl, cyclohexyl and cyclopentyl radicals and the esterifying group is derived from octa-ethylene glycol monomethyl ether, undeca - ethylene glycol monomethyl ether, octa - ethylene glycol, nona - ethylene glycol, nona-ethylene glycol monomethyl ether or mixtures of polyethylene glycols or their methyl esters in which n has an average value between 8 and 12. Glycols. Polyethylene glycols and ethers thereof used in the esterification of the p-aminobenzoic acids are made by known methods. For example, octaethylene glycol monomethyl ether is made by reacting diethylene glycol monomethyl ether benzene sulphonate with triethylene glycol to give pentaethylene glycol monomethyl ether, treating this with benzene sulphonyl chloride to give the benzene sulphonate and reacting this with triethylene glycol to give octaethylene glycol; undecaethylene glycol monomethyl ether is made by treating octaethylene glycol monomethyl ether with benzene sulphonyl chloride to give the corresponding benzene sulphonate which is reacted with triethylene glycol; octaethylene glycol is made by treating diethylene glycol with benzene sulphonyl chloride and reacting the resulting bis-benzenesulphonate with two mols. of triethylene glycol; nonaethylene glycol is made by reacting triethylene glycol bis-benzenesulphonate with two mols. of triethylene glycol and nonaethylene glycol monomethyl ether is made by converting octaethylene glycol monomethyl ether into its monobenzene sulphonate and reacting this with ethylene glycol, or by converting nona-ethylene glycol to its monobenzenesulphonate which is reacted with methyl alcohol, or by treating the monobenzene sulphonate of triethylene glycol with triethylene glycol monomethyl ether with triethylene glycol monobenzenesulphonate. Aromatic acids. p - Aminobenzoic acid derivatives used to esterify polyethylene glycols are made by known methods. For example, the ethyl esters of p-hexylaminobenzoic acid, p-heptylaminobenzoic acid and p-cyclohexylaminobenzoic acid are made by treating ethyl p-aminobenzoate with the appropriate alkyl or cycloalkyl bromide and p-(2-butoxyethylamino) benzoic acid ethyl ester is made by treating p-aminobenzoic acid with ethylene glycol monobutyl ether benzene sulphonate. The Provisional Specification also describes processes for the preparation of compounds of formula I in which an alcohol of the formula <FORM:0788100/IV (b)/3> or its metal salt or reactive ester is reacted with an alcohol of the formula HO-(CH2-CH2-O)p-R1 or its metal salt or reactive ester, m and p being whole numbers such that m+p=n; or in which the group R1 in a compound of the formula <FORM:0788100/IV (b)/4> is converted into the group R-NH-, R1 being a convertible group such as a primary amino group. Specification 728,583 is referred to.ALSO:Pharmaceutical preparations suitable for parenteral or oral administration in the treatment of coughs comprise a compound of the formula <FORM:0788100/VI/1> in which R is an alkyl, cycloalkyl or oxa-alkyl group of 4-7 carbon atoms, R1 is hydrogen or an alkyl radical of 1-6 carbon atoms and n is an integer from 8 to 12 or has an average value from 8 to 12 (see Group IV (b)), plus a pharmaceutical carrier. Examples include a syrup containing nona - ethylene - glycol - mono - methyl ether p-n-butylaminobenzoate or undeca-ethylene-glycol-monomethyl ether p-butylaminobenzoate, sugar, p-hydroxybenzoic acid ester, sodium carboxymethyl cellulose, citric acid, oil of lemon, vanillin, banana essence, "Tween" (Registered Trade Mark) and water; ampoules containing the octaethylene-glycol-monomethyl ether or nonaethylene-glycol-monomethyl ether ester of p-butylaminobenzoic acid, sodium chloride and water and capsules containing the same active ingredient optionally mixed with propylene glycol or stearic acid. Specification 728,583, [Group IV (b)], is referred to.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB13008/54A GB788100A (en) | 1954-05-04 | 1954-05-04 | Manufacture of polyethylene-glycol esters of substituted p-aminobenzoic acids |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB13008/54A GB788100A (en) | 1954-05-04 | 1954-05-04 | Manufacture of polyethylene-glycol esters of substituted p-aminobenzoic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB788100A true GB788100A (en) | 1957-12-23 |
Family
ID=10015146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB13008/54A Expired GB788100A (en) | 1954-05-04 | 1954-05-04 | Manufacture of polyethylene-glycol esters of substituted p-aminobenzoic acids |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB788100A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5141672A (en) * | 1990-01-09 | 1992-08-25 | Westvaco Corporation | Quaternary ammonium fluorescent whitening agent, products thereof |
-
1954
- 1954-05-04 GB GB13008/54A patent/GB788100A/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5141672A (en) * | 1990-01-09 | 1992-08-25 | Westvaco Corporation | Quaternary ammonium fluorescent whitening agent, products thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4302465B1 (en) | ||
| SE7407913L (en) | ||
| IL75337A (en) | Polyenoic acids omega-substituted by a 4,5-dimethoxy-2-methyl-quinone or a 4,5-dimethoxy-2-methyl-phenyl group,process for the preparation thereof and pharmaceutical compositions containing the same | |
| ES8406992A1 (en) | Beta, gamma-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound | |
| GB1457022A (en) | Esters of oxyalkyltheophyllines the preparation thereof and pharmaceutical compositions containint them | |
| SE7906011L (en) | NEW IMIDAZOKINOXALINES AND SALTS THEREOF, SET FOR PREPARATION AND USE THEREOF AS A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | |
| GB788100A (en) | Manufacture of polyethylene-glycol esters of substituted p-aminobenzoic acids | |
| ES8106289A1 (en) | Derivatives of alpha-phenyl-2-pyrrolidine methanol and their salts, process for their preparation, use as medicines and compositions containing them. | |
| IL91620A0 (en) | 4,5-diaryl-2-substituted thioimidazoles,their preparation and pharmaceutical compositions containing them | |
| SE7901098L (en) | 1,1-DISUBSTITUTED OCTAHYDRO-INDOL / 2,3-A / -QINOLIZINES SET FOR THEIR PREPARATION AND PREPARATIONS CONTAINING THEM | |
| GB874868A (en) | Process for preparing esters of epoxidized hydrocarbon drying oils, and resulting products | |
| GB1112909A (en) | Ergoline derivatives | |
| GB1158473A (en) | Derivatives of Benzothiopyrone and process for preparing them | |
| ES479440A1 (en) | Ethanolamine compounds, processes for their preparation, pharmaceutical preparations containing them and their medicinal use. | |
| DE2964850D1 (en) | Thienylbenzoic-acid derivatives, process for their production, and pharmaceutical preparations containing these compounds | |
| ES407867A1 (en) | Phenothiazine derivatives | |
| GB952961A (en) | Substituted propionic acid esters | |
| ES445343A1 (en) | Quaternary xanthinylalkyl nortropine | |
| GB709482A (en) | Polyethylene glycol derivatives and method of making same | |
| GB1088265A (en) | Process for preparing 2, 3-epithioandrostane esters | |
| GB1127992A (en) | Process for the manufacture of theophylline derivatives | |
| HU9200931D0 (en) | Process for the production of medical preparations containing 4,9,11-triene-steroides | |
| GB1107036A (en) | Esters of dibenzocycloheptenyl-carboxylic acids | |
| GB1382958A (en) | Azabicyclic esters of omega- 4-biphenylyl- alkanoic acids | |
| GB1115255A (en) | Improvements in or relating to new ester of dihydroxy-propyl-theophylline, process for its preparation and therapeutic composition containing same |